Ehlers-Danlos syndrome type IV
Open Access
- 19 July 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 2 (1), 32
- https://doi.org/10.1186/1750-1172-2-32
Abstract
Ehlers-Danlos syndrome type IV, the vascular type of Ehlers-Danlos syndromes (EDS), is an inherited connective tissue disorder defined by characteristic facial features (acrogeria) in most patients, translucent skin with highly visible subcutaneous vessels on the trunk and lower back, easy bruising, and severe arterial, digestive and uterine complications, which are rarely, if at all, observed in the other forms of EDS. The estimated prevalence for all EDS varies between 1/10,000 and 1/25,000, EDS type IV representing approximately 5 to 10% of cases. The vascular complications may affect all anatomical areas, with a tendency toward arteries of large and medium diameter. Dissections of the vertebral arteries and the carotids in their extra- and intra-cranial segments (carotid-cavernous fistulae) are typical. There is a high risk of recurrent colonic perforations. Pregnancy increases the likelihood of a uterine or vascular rupture. EDS type IV is inherited as an autosomal dominant trait that is caused by mutations in the COL3A1 gene coding for type III procollagen. Diagnosis is based on clinical signs, non-invasive imaging, and the identification of a mutation of the COL3A1 gene. In childhood, coagulation disorders and Silverman's syndrome are the main differential diagnoses; in adulthood, the differential diagnosis includes other Ehlers-Danlos syndromes, Marfan syndrome and Loeys-Dietz syndrome. Prenatal diagnosis can be considered in families where the mutation is known. Choriocentesis or amniocentesis, however, may entail risk for the pregnant woman. In the absence of specific treatment for EDS type IV, medical intervention should be focused on symptomatic treatment and prophylactic measures. Arterial, digestive or uterine complications require immediate hospitalisation, observation in an intensive care unit. Invasive imaging techniques are contraindicated. Conservative approach is usually recommended when caring for a vascular complication in a patient suffering from EDS type IV. Surgery may, however, be required urgently to treat potentially fatal complications.Keywords
This publication has 73 references indexed in Scilit:
- Fatal Bleeding following Delivery: A Manifestation of the Vascular Type of Ehlers-Danlos’ SyndromeGynecologic and Obstetric Investigation, 2006
- Increased Carotid Wall Stress in Vascular Ehlers-Danlos SyndromeCirculation, 2004
- Vascular Ehlers–Danlos syndromeAnnales de Genetique, 2003
- An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.Journal of Medical Genetics, 1996
- Cavitary pulmonary lesions in type IV Ehlers-Danlos syndromePediatric Radiology, 1994
- The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.Journal of Medical Genetics, 1993
- Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV.Journal of Medical Genetics, 1991
- Cerebrovascular disease in Ehlers-Danlos syndrome type IV.Stroke, 1990
- Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagen.Cell Metabolism, 1981
- Surgical aspects of the Ehlers-Danlos syndrome a survey of 100 casesBritish Journal of Surgery, 1969